eccogene glp 1 Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist - Haggag - 2025 - Diabetes, Obesity and Metabolism AstraZeneca raises stakes in obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2



-agonists-market-key-insight.png)
























![Balefire Dragon [Innistrad] Happy Holidays](https://cdn.shopify.com/s/files/1/0561/0376/4010/files/b0dce4ac-f472-4f3b-b01a-eff0902a578f.png?v=1758990337)
